<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sonic hedgehog (SHH) signaling pathway promotes the process of <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, contributing to the growth and progression of many human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), which therefore has become a promising target for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>Hedyotis diffusa Willd (HDW), as a well-known traditional Chinese herbal medicine, has long been used in China for the clinic treatment of various <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, we reported that HDW can inhibit <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> growth in vivo and in vitro via suppression of the STAT3 pathway </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, we demonstrated the anti-angiogenic activity of HDW in vitro </plain></SENT>
<SENT sid="4" pm="."><plain>To further elucidate the mechanism of the tumoricidal activity of HDW, by using a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> mouse <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> we evaluated the in vivo effect of the <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> extract of HDW (EEHDW) on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, and investigated the underlying molecular mechanisms </plain></SENT>
<SENT sid="5" pm="."><plain>We found that EEHDW could significantly reduce intratumoral microvessel density (MVD), indicating its activity of antitumor <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in vivo </plain></SENT>
<SENT sid="6" pm="."><plain>EEHDW suppressed the activation of SHH signaling in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> xenograft <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> since it significantly decreased the expression of key mediators of SHH pathway </plain></SENT>
<SENT sid="7" pm="."><plain>EEHDW treatment inhibited the expression of the critical SHH signaling target gene VEGF-A as well as its specific receptor VEGFR2 </plain></SENT>
<SENT sid="8" pm="."><plain>Taken together, we propose for the first time that Hedyotis diffusa Willd inhibits <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> growth in vivo via inhibition of SHH-mediated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
</text></document>